Advances and Collaborations Emerge from Scientific Advisory Board Meeting at the DRI

In a dynamic convergence of scientific minds, the Diabetes Research Institute (DRI) recently hosted a pivotal gathering of experts in the field of diabetes research who form its Scientific Advisory Board (SAB). The SAB, appointed through collaboration between the DRI Foundation and University of Miami leadership, plays a crucial role in evaluating DRI research programs, assessing progress, and offering guidance

The SAB undertook a comprehensive review, evaluating a total of 25 projects presented by 19 investigators from within the DRI. These projects spanned diverse areas of inquiry, including beta-cell regeneration, disease screening methodologies, understanding of pathogenesis and innervation pathways, prevention of autoimmunity, and advancements in devices for islet cell transplants and drug discovery.

Dr. Matthias von Herrath, Scientific Director of the DRI, outlined the Institute’s strategic vision emphasizing the formation of affinity groups aimed at fostering interdisciplinary collaboration and synergy. Dr. Jay Skyler, Deputy Director of the DRI, presented an overview of the combination therapy approach, shedding light on innovative strategies for tackling the complexities of diabetes.

Reflecting on the meeting, participants expressed enthusiasm and optimism about the progress being made. “I commend the exceptional organization and effectiveness of our recent DRI-SAB meeting,” remarked SAB member, Christopher Newgard, Director of Sarah W. Stedman Nutrition and Metabolism Center and Duke Molecular Physiology Institute, Duke University Medical Center. “Over my 20+ years of service as a member of the DRI SAB, I found this to be the most outstanding meeting I have attended in terms of intellectual engagement, seamless execution, and exciting scientific advances.”

SAB members offered valuable insights and perspectives that promise to shape the future direction of diabetes research. Importantly, the gathering also served as a catalyst for forging new partnerships and collaborations within the DRI and with other institutions and stakeholders.

As the scientific community continues to mobilize its efforts toward prevention and cure for diabetes, the outcome of this meeting stands as testament to the power of collaboration, innovation, and collective expertise in driving meaningful progress. With a shared commitment to advancing knowledge and improving outcomes for patients, the path toward a cure grows ever closer.


Keep Up With Our Progress Toward A Cure & More